Nuveen Securitized Income (NSCI) ETF Holdings & Analysis
ETFOther
$25.08-0.02%
52-week range$25.08
$25.00$25.47
What NSCI does
This actively managed approach seeks to generate compelling returns, optimized for the level of risk taken, by strategically investing in a diverse collection of structured credit products.
Fund profile
Category
Other
AUM
$212.52M
Holdings
10
52-week high
$25.47
52-week low
$25.00
Top holdings
| Holding | Weight | |
|---|---|---|
| STATE STREET INSTITUTION | 2.30% | |
| CAS 2023-R VRN 09/25/2043 | 1.90% | |
| U.S. DOLLARS | 1.57% | |
| NYCT 2024- VRN 08/15/2029 | 1.52% | |
| FN MA5107# 5.50% 8/1/53 | 1.50% | |
| ARDN 2025- VRN 06/15/2035 | 1.39% | |
| JPMMT 2025 VRN 05/25/2056 | 1.37% | |
| JPMMT 2026 VRN 12/01/2066 | 1.19% | |
| CHASE 2025 VRN 07/25/2056 | 1.13% | |
| CAS 2023-R VRN 05/25/43 | 1.08% |
Geographic allocation
| United States | 2.78% |
| Other | 97.22% |
PortView Portfolio Insights
PortView analyzes how NSCI fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NSCI in PortView →Related securities
Related stocks
Frequently asked questions
- What does NSCI track?
- NSCI is the Nuveen Securitized Income, a Other ETF.
- What is the expense ratio of NSCI?
- Expense ratio data for NSCI is shown on the page when available from our data provider.
- What are the largest holdings in NSCI?
- Top holdings include GVMXX, CAS 2023-R VRN 09/25/2043, U.S. DOLLARS, NYCT 2024- VRN 08/15/2029, FN MA5107# 5.50% 8/1/53.
- How can PortView analyze NSCI overlap with other ETFs?
- PortView computes the holdings overlap between NSCI and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.